Excessive lung inflammation is a major factor in the morbidity associated with cystic fibrosis. Despite the lack of evidence of convincing benefit,1 ,2 corticosteroids are being increasingly prescribed to children with cystic fibrosis to reduce this inflammation, whilst ibuprofen has also been advocated as a useful anti-inflammatory agent. We wished to ascertain current prescribing practice in the UK, so carried out a postal survey of all specialist cystic fibrosis centres treating …